Yellow Fever Treatment Market, by Transmission Type (Sylvatic Yellow Fever, Intermediate Yellow Fever, and Urban Yellow Fever), by Treatment Type (Vaccines, Medications, and Others), by Application (Hospitals, Clinics, Community Health Centers, and Others

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	191 Pages	Coherent Market Insights	May, 2022	CMI17213164

Best Price Guarantee
Price	from $4,500
Length	191 Pages
Publisher	Coherent Market Insights
Published Date	May, 2022
SKU	CMI17213164

Yellow Fever Treatment Market, by Transmission Type (Sylvatic Yellow Fever, Intermediate Yellow Fever, and Urban Yellow Fever), by Treatment Type (Vaccines, Medications, and Others), by Application (Hospitals, Clinics, Community Health Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Yellow fever is a serious disease spread by Aedes aegypti mosquitoes, which also transmit dengue and Zika viruses. Mosquitoes normally breed in tropical rainforests, semi-humid environments, and humid environments, as well as around bodies of still water. Increased contact between humans and infected mosquitoes, specifically in areas where people haven’t been vaccinated for yellow fever, can create small-scale epidemics. The WHO estimates that 50% of people who develop severe symptoms of this condition die. Older adults and those with compromised immune systems are at a risk for serious complications. The common symptoms of yellow fever include headache, nausea, fever, and vomiting. In severe cases, yellow fever affects some key organs such as the heart, kidney, and liver.
Market Dynamics
The increasing research and studies on yellow fever are expected to drive the global yellow fever treatment market growth during the forecast period. For instance, the Epicentre study, in collaboration with the Kenya Medical Research Institute, Institut Pasteur de Dakar, and WHO, carried out a randomized, double-blind trial in Mbarara, Kenya, Kilifi, and Uganda. The trial was carried out between November 6, 2017 and February 21, 2018. During this period, researchers administered one-fifth of a standard dose of yellow fever vaccine to about 960 adults between the ages of 18 and 59 years. In this study, it was found that giving people just one-fifth of a yellow fever vaccine was as effective as giving them a full dose. This means that more lives can be saved during outbreaks of the deadly disease. This study was led by Epicentre, the research arm of Médecins Sans Frontières / Doctors without Borders (MSF).
Key features of the study:
This report provides an in-depth analysis of the global yellow fever treatment market, market size (US$ Mn), and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global yellow fever treatment market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Sanofi Pasteur SA, Janssen, Pfizer Inc., BIOCRYST PHARMACEUTICALS, INC., Tychan Pte. Ltd., Johnson & Johnson Services, Inc., Takeda Pharmaceutical Company Limited, Bayer AG, GlaxoSmithKline plc, Bio-Manguinhos, Institut Pasteur de Dakar, and FSUE Chumakov
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global yellow fever treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global yellow fever treatment market
Detailed Segmentation:
Global Yellow Fever Treatment Market, By Transmission Type:
Sylvatic Yellow Fever
Intermediate Yellow Fever
Urban Yellow Fever
Global Yellow Fever Treatment Market, By Treatment Type:
Vaccines
Medications
Others
Global Yellow Fever Treatment Market, By Application:
Hospitals
Clinics
Community Health Centres
Others
Global Yellow Fever Treatment Market, By Region:
North America
Transmission Type
Sylvatic Yellow Fever
Intermediate Yellow Fever
Urban Yellow Fever
Treatment Type
Vaccines
Medications
Others
Application
Hospitals
Clinics
Community Health Centers
Others
By Country
U.S.
Canada
Latin America
Transmission Type
Sylvatic Yellow Fever
Intermediate Yellow Fever
Urban Yellow Fever
Treatment Type
Vaccines
Medications
Others
Application
Hospitals
Clinics
Community Health Centers
Others
By Country
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Transmission Type
Sylvatic Yellow Fever
Intermediate Yellow Fever
Urban Yellow Fever
Treatment Type
Vaccines
Medications
Others
Application
Hospitals
Clinics
Community Health Centers
Others
By Country
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Transmission Type
Sylvatic Yellow Fever
Intermediate Yellow Fever
Urban Yellow Fever
Treatment Type
Vaccines
Medications
Others
Application
Hospitals
Clinics
Community Health Centers
Others
By Country
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Transmission Type
Sylvatic Yellow Fever
Intermediate Yellow Fever
Urban Yellow Fever
Treatment Type
Vaccines
Medications
Others
Application
Hospitals
Clinics
Community Health Centers
Others
By Country
GCC
Israel
Rest of Middle East
Africa
Transmission Type
Sylvatic Yellow Fever
Intermediate Yellow Fever
Urban Yellow Fever
Treatment Type
Vaccines
Medications
Others
Application
Hospitals
Clinics
Community Health Centers
Others
By Country/Region
South Africa
Central Africa
North Africa
Company Profiles
Sanofi Pasteur SA*
Company Highlights
Products Portfolio
Key Highlights
Financial Performance
Strategies
Janssen
Pfizer Inc.
BIOCRYST PHARMACEUTICALS, INC.
Tychan Pte. Ltd.
Johnson & Johnson Services, Inc.
Takeda Pharmaceutical Company Limited
Bayer AG
GlaxoSmithKline plc
Bio-Manguinhos
Institut Pasteur de Dakar
FSUE Chumakov
“*” marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Transmission Type; Market Snapshot, By Treatment Type; Market Snapshot, By Application; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Drivers; Restraints; Opportunity; Impact Analysis; Key Highlights; Regulatory Scenario; Product Launches / Approvals; PEST Analysis; PORTER’s Analysis; Merger, Collaboration and Acquisitions Scenario
4. Global Yellow Fever Treatment Market– Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply side and Demand Side Analysis; Economic Impart
5. Global Yellow Fever Treatment Market, By Transmission Type, 2017 - 2028, (US$ Mn): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Sylvatic Yellow Fever; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); Intermediate Yellow Fever; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn); Urban Yellow Fever; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Yellow Fever Treatment Market, By Treatment Type, 2017 - 2028, (US$ Mn): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Vaccines; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Medications; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Yellow Fever Treatment Market, By Application, 2017 - 2028, (US$ Mn): Introduction; Market Share Analysis, 2022 and 2028 (%); Y-o-Y Growth Analysis, 2017 - 2028; Segment Trends; Hospitals; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Community Health Centers; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
8. Global Yellow Fever Treatment Market, By Region, 2017 - 2028, (US$ Mn): Introduction; Market Share Analysis, By Region, 2022 and 2028 (%); Y-o-Y Growth Analysis, For Regions, 2017–2028; Regional Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn); U.S.; Canada; Latin America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn); Brazil; Mexico; Argentina; Rest of Latin America; Europe; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn); U.K.; Germany; France; Italy; Spain; Russia; Rest of Europe; Asia Pacific; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn); China; India; Japan; Australia; South Korea; ASEAN; Rest of Asia Pacific; Middle East; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 - 2028, (US$ Mn); GCC; Israel; Rest of Middle East; Africa; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Transmission Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2028, (US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Countries/Region, 2017 - 2028, (US$ Mn); North Africa; Central Africa; South Africa
9. Competitive Landscape: Heat Map Analysis; Market Share Analysis; Sanofi Pasteur SA; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Janssen; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Pfizer Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; BIOCRYST PHARMACEUTICALS, INC.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Tychan Pte. Ltd.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Johnson & Johnson Services, Inc.; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Takeda Pharmaceutical Company Limited; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Bayer AG; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; GlaxoSmithKline plc; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Bio-Manguinhos; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Institut Pasteur de Dakar; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; FSUE Chumakov; Company Highlights; Product Portfolio; Key Highlights; Financial Performance; Strategies; Analyst Views
10. Section: Research Methodology; About us; *Browse 28 market data tables and 23 figures on "Yellow Fever Treatment Market” - Global forecast to 2028